Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer: Assessing the Value of Repeated Centralized Testing in Excision Specimens-Reference-Cited by-同舟云学术

Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor-2 Testing in Breast Cancer: Assessing the Value of Repeated Centralized Testing in Excision Specimens

Published:2019-01 Issue:1 Volume:27 Page:1-7
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Hariri Nosaibah,Hasteh Farnaz,Walavalkar Vighnesh,Roma Andres A.,Fadare Oluwole

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference43 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update;Wolff;J Clin Oncol,2013

3. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version);Hammond;Arch Pathol Lab Med,2010

4. Interventional breast procedures;de Paredes;Curr Probl Diagn Radiol,1998

5. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis;Chen;Breast Cancer Res Treat,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New fluorobenzamidine exerts antitumor activity against breast cancer in mice via pro-apoptotic activity;Discover Oncology;2022-09-15